SynthesisPediatric cardiology2026
Acquired Conduction Disease in Pediatric Myocarditis: A Review of the Literature and Case Series.
Synthesis in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocarditis is an important cause of mortality, and particularly sudden death, in children. Arrhythmias, particularly tachyarrhythmias, are a known clinical sequelae of myocarditis. Bradyarrhythmias and conduction disease in pediatric myocarditis are a less common, but potentially critical complication of myocarditis, which may be associated with increased morbidity and mortality. Pediatric myocarditis with effects on atrioventricular conduction and ventricular conduction represents an underexplored and clinically significant field. We conducted a systematic review of the published literature and present two cases of significant conduction disease. Literature searches were performed as per PRISMA guidelines in Medline, EMBASE, Web of Science, and Cochrane Systematic Reviews. We analyzed 53 articles and identified 175 published cases of atrioventricular (AV) conduction disease and bradyarrhythmias in pediatric myocarditis. Diagnostic approaches were varied among the studies, with heterogeneity in both serum investigations, cardiac imaging, and management of the conduction issues. There were 91 cases of complete heart block, 53 cases of first-degree heart block, 11 cases of second-degree heart block, and 10 reported cases of clinically significant sinus bradycardia. Of the 175 reported cases, 31 required temporary pacing, with 10 having a pacemaker implanted, and the remaining were treated with medical therapy alone and did not require pacemaker placement. In this review, there were 13 deaths among the 175 reported cases, all of whom had complete heart block. AV conduction disease in pediatric myocarditis, although less common, can be clinically significant and have severe outcomes. The variation in presentation, treatment, outcome, and diversity in pathogens warrants further study in order to improve our understanding of this potential complication of myocarditis.
Indexed as
Identifiers
40996541What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.